The purpose of the study is to evaluate how the body processes the medication and to monitor its safety. Researchers will observe how the drug is absorbed into the bloodstream, how it moves throughout the body, and how it is eventually eliminated. Additionally, the study will track how the body reacts to the treatment to ensure it is safe for use in this age group.

During the study, infants will receive either dexmedetomidine or a placebo through an intravenous infusion, which means the medication is delivered directly into a vein. Participants will be assigned to one of these two groups by chance. The process involves monitoring the infants while they are receiving breathing support to see how the different treatments affect their need for pain medication and their overall comfort levels.

Patients in this study will be randomly assigned to receive either the spinal morphine injection or the epidural pain relief method. Both groups will also receive additional pain medications as needed to keep them comfortable. The study will measure how well patients are recovering using a questionnaire that asks about their overall well-being and recovery quality. This will be checked on the second day after surgery and at several other times up to one year after the operation. The study will also track pain levels, patient satisfaction with pain control, how quickly patients can move around and return to normal activities, how long they stay in the hospital, and whether they experience any unwanted effects from the treatments.

Throughout the study, various aspects of recovery will be monitored, including how much additional pain medication patients need, whether they experience side effects such as nausea, itching, drowsiness, or breathing problems, and how quickly their bowel function returns to normal. The study will also look at overall health-related quality of life, any confusion after surgery, and whether patients develop any complications. For patients who have cancer, the study will track when they are able to start chemotherapy treatment if needed. All of these measurements help researchers understand which pain control method allows for better recovery after colorectal surgery.

The main purpose of this study is to determine how well the lower concentration of medication works in providing pain relief compared to the standard higher concentration. During the study, other medications may also be used as needed, including fentanyl for additional pain relief and ropivacaine as an alternative local anesthetic. The effectiveness of the pain relief will be measured at various times during labor.

Throughout labor, healthcare providers will monitor the mother’s pain levels, ability to move, and overall comfort. They will also track how the different medication concentrations might affect the delivery process and the newborn’s health. The study will evaluate patient satisfaction with the pain relief method and record any complications that may occur during or after the procedure.

The study aims to compare different methods of sedation and pain control in critically ill patients who need both deep sedation and muscle relaxation. These patients are typically those with severe conditions requiring breathing support through mechanical ventilation, increased pressure in the brain, or continuous seizures. The study will monitor how different combinations of medications and monitoring methods affect the amount of pain medication needed.

During the study, patients will receive either intravenous sedation medications or inhaled sedation, along with pain medications. Some patients will have their pain levels monitored using a special device called NOL (Nociception Level) monitor, while others will receive standard care without this monitoring. The study will track various aspects of patient care, including breathing status, heart function, brain monitoring, and the development of any infections.

The research involves testing two different treatments: icatibant and a placebo. Both treatments will be given through intravenous injection, which means they are delivered directly into a vein. The study uses propofol in the form of an injection/infusion solution called Propolipid, along with a salt solution to dilute the medications.

During the study, participants will receive both treatments at different times, and their pain levels will be measured using a special scale. The total duration of treatment for each participant is expected to be very short, lasting only a few days. This is a carefully controlled study where neither the participants nor the healthcare providers know which treatment is being given at any particular time.

The purpose of the study is to determine how many participants experience significant pain when Propofol is injected intravenously, which means directly into a vein. Participants will receive either Propofol or a placebo through an intravenous bolus, which is a method of delivering a medication quickly into the bloodstream. The study will involve both male and female participants who are healthy and between the ages of 18 and 50.

Throughout the study, participants will be monitored to assess the level of pain they experience using a tool called the Visual Analog Scale (VAS), which measures pain on a scale from 0 to 100. The study will also use the Numeric Rating Scale (NRS) to measure pain on a scale from 0 to 10. The trial aims to gather information on the intensity and duration of pain following the injection, helping to better understand and manage pain associated with Propofol injections.

The purpose of this research is to understand how a single dose of clonidine given through an intravenous injection affects post-surgical pain in patients who have had colectomy surgery. During the study, participants will receive either clonidine or placebo through an injection into their vein. The maximum daily dose of clonidine used in the study is 750 micrograms.

The study will monitor various aspects of patient recovery after surgery, including pain levels, vital signs (such as blood pressure and heart rate), and the amount of other pain medications needed. Blood samples will be collected to measure medication levels in the body. The treatment period lasts for one day after the surgery.

The purpose of the study is to evaluate how effective the betamethasone injections are in reducing knee pain when guided by ultrasound, a technique that uses sound waves to create images of the inside of the body. Participants in the study will receive either the betamethasone injection or a placebo injection, and their pain levels will be monitored over a period of one month. The study will also track any changes in pain over three months and any side effects that may occur.

Participants will undergo an initial assessment, including an MRI (Magnetic Resonance Imaging) scan of the knee, to confirm the presence of a degenerative meniscal lesion. The study aims to determine if the betamethasone injection can significantly reduce pain compared to the placebo, with the primary focus on changes in pain levels measured by a Visual Analog Scale (VAS), a tool used to assess pain intensity. The study will also evaluate the overall knee function using the KOOS score, which measures knee-related quality of life.

In this study, some infants will receive clonidine, while others may receive a placebo. The medication is given orally, which means it is taken by mouth. The study will observe the infants during the eye examination to see how well the medication works in reducing pain. The researchers will look at different signs of pain and comfort in the infants to assess the effectiveness of clonidine.

The study will take place over a period of time, and the researchers will collect data on how the infants respond to the treatment. The goal is to find out if clonidine can be a helpful and safe option for managing pain during these important eye examinations in premature infants. The study is expected to continue until the end of 2026.

The medications being studied in this trial include DEXAMETHASONE SODIUM PHOSPHATE, ROPIVACAINE, and LIDOCAINE HYDROCHLORIDE. DEXAMETHASONE SODIUM PHOSPHATE is a corticosteroid used to reduce inflammation. ROPIVACAINE and LIDOCAINE HYDROCHLORIDE are local anesthetics, which means they are used to numb a specific area of the body to prevent pain during procedures. These medications are administered through injections, with ROPIVACAINE and LIDOCAINE HYDROCHLORIDE being used for local anesthesia, and DEXAMETHASONE SODIUM PHOSPHATE potentially being used to enhance the effects of the anesthetics.

The purpose of the study is to assess how effective the serratus plane block is compared to local anesthesia in managing acute pain during pleural drainage. Participants in the study will receive one of these pain management methods during their procedure. The study will monitor the intensity of pain experienced during and after the procedure, as well as any potential side effects or complications. The trial aims to provide valuable information on the best approach to pain management for patients undergoing pleural drainage in intensive care settings.

Participants in the study will receive either the ketamine treatment or a placebo, which is an inactive substance. The ketamine is given as an injection, and the study will monitor the total amount of pain medication needed, as well as other factors like pain levels, any side effects such as nausea or delirium, and overall recovery. The study will also look at how long patients stay in the hospital and their quality of life after treatment.

The goal is to find out if ketamine can help manage pain more effectively in trauma patients, potentially leading to better outcomes and less reliance on opioids, which are strong painkillers that can have significant side effects. This research could provide valuable insights into improving pain management strategies for people who have suffered serious injuries.

Participants in the study will receive either *Levobupivacaine* or a placebo during their ESD procedure. The study will monitor pain levels at several intervals: within 90 minutes, 6 hours after the procedure, and daily for up to 14 days. The study will also track the overall use of pain relief medications during this period. Additionally, the study will observe any side effects related to the use of *Levobupivacaine*, including allergic reactions, and will record the length of hospital stay.

Other medications involved in the study include *Paracetamol* and *Diclofenac Sodium*, which are commonly used for pain relief. These medications may be used alongside *Levobupivacaine* to manage pain. The study aims to provide a better understanding of how effective *Levobupivacaine* is in managing pain after ESD and to ensure the safety of its use in this context.

In this study, some children will receive dexmedetomidine, while others will receive a placebo, which looks like the medication but does not contain any active ingredients. The purpose of the study is to determine if dexmedetomidine is a safe and effective option for sedation and pain relief in the pediatric emergency room setting.

The study will observe how well the procedures go on the first try, how long they take, and how comfortable the children feel during the process. It will also look at the children’s pain levels, sedation levels, and other factors like heart rate and oxygen levels. The study aims to provide valuable information on whether dexmedetomidine can be a helpful tool for managing pain and anxiety in young patients undergoing minor medical procedures.

During the study, patients will receive either the inhalation sedation with isoflurane or the conventional intravenous sedation, which may include medications like propofol or midazolam. The study will monitor various aspects of the patients’ sedation levels, such as how deeply they are sedated and how much medication is needed. It will also look at other health factors, including breathing, heart function, and any potential side effects. The study aims to see if the inhalation method can provide effective sedation while being safe for the patients.

The trial will also collect information on how long patients stay in the intensive care unit (ICU) and the hospital, as well as any changes in liver or kidney function. Additionally, the study will observe the patients’ recovery process, including how quickly they wake up and whether they experience confusion or delirium. This research hopes to provide valuable insights into the best sedation practices for patients with severe brain conditions.

Participants in the study will receive one of the three treatments. Fentanyl and Ketamine will be given through the nose using a special device, while Morphine will be taken by mouth. The study will monitor the children’s pain levels at various times after receiving the medication, specifically at 15, 30, 60, 90, and 120 minutes. The study will also observe any side effects, such as drowsiness, dizziness, or nausea, and assess the overall satisfaction of the children and their parents with the treatment.

The purpose of this study is to improve pain management for children with limb injuries in emergency settings. By comparing these treatments, the study aims to identify the most effective and satisfactory method for reducing pain quickly and safely. The trial is expected to continue until June 2027, with recruitment starting in June 2024.

The medication used in this study is called Levobupivacaine hydrochloride, which is a local anesthetic that helps numb the area to reduce pain. Participants in the study will be divided into two groups, with one group receiving the wound infiltration method and the other receiving the transversus abdominis plane block. The purpose of the study is to compare the total amount of opioid pain medication needed by each group within 48 hours after surgery, expressed in terms of morphine milligram equivalent.

Throughout the study, researchers will also observe and compare other factors such as pain levels at rest and during movement, the occurrence of nausea and vomiting, and the time it takes for patients to start eating, moving around, and being discharged from the hospital. The study will help determine which pain management technique is more effective in reducing the need for additional pain medication and improving recovery after laparoscopic colorectal surgery.